Home
>
National Drug Code (NDC)
>
Kepivance
Kepivance - 66658-112-24 - (palifermin)
Drug Information of Kepivance
| Product NDC: | 66658-112 |
| Proprietary Name: | Kepivance |
| Non Proprietary Name: | palifermin |
| Active Ingredient(s): | 6.25 mg/1.2mL & nbsp; palifermin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Kepivance
| Product NDC: | 66658-112 |
| Labeler Name: | Swedish Orphan Biovitrum AB (publ) |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125103 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20091215 |
Package Information of Kepivance
| Package NDC: | 66658-112-24 |
| Package Description: | 4 CARTON in 1 BOX (66658-112-24) > 6 VIAL, SINGLE-USE in 1 CARTON (66658-112-06) > 1.2 mL in 1 VIAL, SINGLE-USE (66658-112-01) |
NDC Information of Kepivance
| NDC Code | 66658-112-24 |
| Proprietary Name | Kepivance |
| Package Description | 4 CARTON in 1 BOX (66658-112-24) > 6 VIAL, SINGLE-USE in 1 CARTON (66658-112-06) > 1.2 mL in 1 VIAL, SINGLE-USE (66658-112-01) |
| Product NDC | 66658-112 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | palifermin |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20091215 |
| Marketing Category Name | BLA |
| Labeler Name | Swedish Orphan Biovitrum AB (publ) |
| Substance Name | PALIFERMIN |
| Strength Number | 6.25 |
| Strength Unit | mg/1.2mL |
| Pharmaceutical Classes | Fibroblast Growth Factor 7 [Chemical/Ingredient],Increased Epithelial Proliferation [PE],Mucocutaneous Epithelial Cell Growth Factor [EPC] |
